On the coast of the East China Sea, along the Huangpu River, the optometry industry welcomed a long-awaited industry event as the haze of the epidemic dissipated and the spring blossomed. From April 1st to 3rd, the 21st China (Shanghai) International Optics Fair, themed “Integration and Innovation | Future Vision”, was grandly held at the Shanghai World Expo Exhibition and Convention Center. The venue was crowded with people and the atmosphere was lively.
SIOF is one of the most influential and largest world-class optometry exhibitions in Asia. Professionals and practitioners from the global optometry industry are enthusiastic about the event, with a diverse range of academic lectures, product releases, and marketing activities, making it a dazzling and exciting event. Attendees can share and exchange the latest technological innovations and future developments in the industry.
Big Vision Medical Technology
As a leader in the ophthalmic AI industry, Big Vision Medical actively expands the application of ophthalmic AI in the optometry field. The company is dedicated to enhancing the professional technical service capabilities of the optometry industry through advanced AI empowerment. During this event, Big Vision brought a series of intelligent ophthalmic hardware and software products to showcase a comprehensive solution for eye health. This attracted the attention of many customers.
During the exhibition, customers who came to Big Vision’s booth to experience products and consult on business negotiations were constantly present, creating a warm and lively atmosphere at the scene.
With its innovative research and development strength and technical accumulation in the field of ophthalmic AI, Big Vision has attracted wide attention with its products. The independently developed Children and Adolescent Prevention and Warning System and Bright Lemon Optometry Management System can seamlessly connect with equipment such as vision screening instruments, computerized optometers, and electronic vision charts, providing a “device + platform” holistic solution for eye health. Big Vision’s products received unanimous praise from visitors at the event. The BVS200 series of visual screening instruments left a deep impression on users with its “objective · accurate · fast · easy-to-use” product features, and garnered cooperation intentions from many domestic and foreign customers.
In recent years, the use of repeated low-intensity red light irradiation as an adjunct treatment for myopia control has rapidly developed and become a hot topic at the International Eyewear Exhibition. In July 2022, the “Expert Consensus on Repeated Low-Intensity Red Light Irradiation-Assisted Treatment for Children and Adolescents with Myopia” was released, which will further promote the standardized and positive development of low-intensity red light irradiation treatment. To ensure the safety of low-intensity red light irradiation, the “Expert Consensus” clearly states that OCT (including choroidal thickness) examination of the macula should be performed before and during the treatment process.
Big Vision’s fully automatic artificial intelligence OCT BV1000T is designed specifically for the field of optometry, and is considered the best choice for OCT in the optometry business. Advanced deep learning technology automatically achieves pupil positioning and focusing. The examinee only needs to place their chin on the support to complete a comprehensive eye exam within 2 minutes. The device’s convenience and ease of use bring a new experience to users, attracting many visitors to try it out. Some even couldn’t resist learning how to operate the equipment on the spot, and after successfully completing the examination, they praised the device’s ease of use.
In terms of fundus knowledge, optometrists are relatively weaker, but Big Vision’s globally leading AI OCT imaging technology adds an intelligent ophthalmology professional assistant to the optometry center. It can accurately identify and segment lesions in 16 major ophthalmic diseases. At the same time, low-intensity red light irradiation, corneal modeling, and low-concentration atropine and other myopia intervention measures can observe choroidal thickening phenomenon. Big Vision’s fully automatic artificial intelligence OCT can automatically segment and measure the thickness of the choroid, and display the effect of myopia intervention treatment more intuitively.
The significant product advantages of Big Vision’s fully automatic artificial intelligence OCT in the field of optometry have been recognized and affirmed by the leading enterprises in the field of low-intensity red light therapy.
At this exhibition, Big Vision’s fully automatic artificial intelligence OCT was not only exhibited at their own booth, but also displayed at the booths of Ellex Medical, Eagle Eye Technology and Visionary Medical.
During the exhibition, more than 300 people experienced the intelligent, accurate and efficient OCT, allowing more optometrists to understand this product.
Looking forward to meeting again in the golden autumn.
“Detecting every problematic eye early and providing the best treatment plan” is our goal. In the future, Big Vision will fully leverage its technological innovation advantages to provide technical support for the cause of eye health, and we also look forward to meeting again next time!
No comments yet.